NRX Pharmaceuticals, Inc. Shareholders' Equity
NRX Pharmaceuticals, Inc. (NRXP) had Shareholders' Equity of -$170.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$170.00K.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$13.82M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$15.94M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$25.75M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$170.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$13.82M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$15.94M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$25.75M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$35.62M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$25.16M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$23.22M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$18.82M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$18.39M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | -$15.07M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | -$11.73M 10-K · filed 2026-03-23 | |
| 2023-09-30 | -$6.22M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$2.81M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$284.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $7.41M 10-K · filed 2025-03-14 | |
| 2022-09-30 | $16.78M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $25.35M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $31.69M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $20.81M 10-Q · filed 2023-11-14 | |
| 2021-09-30 | $8.48M 10-Q · filed 2022-11-14 | $8.97M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$39.77M 10-Q · filed 2022-11-14 | -$17.44M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $6.39M 10-Q · filed 2022-11-14 | $1.22M 10-Q · filed 2021-05-21 |
| 2020-12-31 | -$43.77M 10-K · filed 2023-03-31 | $2.77M 10-K · filed 2021-04-01 |
| 2020-09-30 | -$2.83M 10-Q/A · filed 2022-08-12 | $3.20M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$5.92M 10-Q/A · filed 2022-08-12 | $3.63M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$6.12M 10-Q/A · filed 2022-08-12 | $3.78M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$4.84M 10-Q/A · filed 2022-08-12 | $5.00M 10-K · filed 2020-03-30 |
| 2019-09-30 | $5.00M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $5.00M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $5.00M 10-Q · filed 2020-11-16 | |
| 2018-12-31 | $5.00M 10-K/A · filed 2021-05-14 | |
| 2018-09-30 | $5.00M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $5.00M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $5.00M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $5.00M 10-K · filed 2020-03-30 | |
| 2017-09-17 | $0.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |